GBA Medical Device Services now has an updated GLP (Good Laboratory Practice) certificate following the successful move to a new, state-of-the-art laboratory. This means that we are still ideally positioned to meet your requirements even more flexibly, efficiently and with the highest quality standards.

Our partner Intercolab in Turkey has successfully obtained accreditation according to TS EN ISO/IEC 17020:2012!

This accreditation ensures that sampling is organised and carried out in accordance with the highest quality standards under accreditation. This ensures that reliability is guaranteed throughout the supply chain, from sampling to analysis.

With the acquisition of the Swedish company Safe Control Materialteknik i Göteborg AB (Safe Control) GBA Group is expanding its regional presence in Sweden. After successfully entering the pharmaceutical and medical device market there last year, Safe Control meaningfully complements the GBA Group's service portfolio in the area of environmental and material analysis.

Rob Lotthrincx has started as the new Managing Director of ABF Pharmaceutical Services GmbH (ABF) in Vienna on August 1st, 2024.

Dear Rob, it is so great to see that you have been so well received. We are font to have you, your many years of experience as a leader and your profound expertise in pharma logistics and supply chain management on board.

Regulation (EU) 2023/915 is being updated to make the rules on contaminants in food clearer. These adjustments are listed in regulation (EU) 2024/1756. New rules are introduced for testing for certain substances in cereals, baby food and oat products. It also clarifies the rules for maximum amounts of harmful substances in rice products, animal products and cereal products. Below in tabular form is an overview of the changes effective July 16, 2024.